Segment features Kevin Lundquist discussing his decision to join Outlook Therapeutics and the Company’s path forward following the FDA approval of LYTENAVA™ ISELIN, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE ...
European Affiliate, based in Amsterdam, to support upcoming marketing authorization submissions, OCU410 Phase 3 development program, and potential commercialization in Europe; MAL ...
Dhaka topped the list of the world’s most polluted cities on Tuesday, with an Air Quality Index (AQI) score of 217, indicating “very unhealthy” air quality.The city’s air pollution is being driven by ...
Analyzing data from the Global Cancer Observatory's Cancer Today (GLOBOCAN) database, the authors estimate 2.3 million new ...
Fall is here and the month of October will bring cooler and dryer weather to our gardens. Well, dryer except if hurricanes ...
"Holsteins are active all over the world, but do they become genetically different cows depending on where they live?"We received this question from a listener.High-altitude Switzerland.Countries with ...
"Through this grant and our partnership with the American Heart Association, we are investing in community-based solutions that can help more people understand their heart health and take steps to ...
Epigenetics has traveled a remarkable distance since the term first entered the scientific vocabulary more than 75 years ago. What began as an abstract question about how genes and their products ...
Scientists say tailored disease treatments require a comprehensive assessment of a person’s lifelong environmental exposures.
The John D. and Catherine T. MacArthur Foundation unveiled its 2026 class of fellows on Tuesday, an interdisciplinary list of 20 individuals ranging from artists to scientists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results